| Literature DB >> 22848339 |
Ganlu Hu1, Kevin Huang, Juehua Yu, Sailesh Gopalakrishna-Pillai, Jun Kong, He Xu, Zhenshan Liu, Kunshan Zhang, Jun Xu, Yuping Luo, Siguang Li, Yi E Sun, Linda E Iverson, Zhigang Xue, Guoping Fan.
Abstract
Retinal pigment epithelium (RPE) cells can be obtained through in vitro differentiation of both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). We have previously identified 87 signature genes relevant to RPE cell differentiation and function through transcriptome analysis of both human ESC- and iPSC-derived RPE as well as normal fetal RPE. Here, we profile miRNA expression through small RNA-seq in human ESCs and their RPE derivatives. Much like conclusions drawn from our previous transcriptome analysis, we find that the overall miRNA landscape in RPE is distinct from ESCs and other differentiated somatic tissues. We also profile miRNA expression during intermediate stages of RPE differentiation and identified unique subsets of miRNAs that are gradually up- or down-regulated, suggesting that dynamic regulation of these miRNAs is associated with the RPE differentiation process. Indeed, the down-regulation of a subset of miRNAs during RPE differentiation is associated with up-regulation of RPE-specific genes, such as RPE65, which is exclusively expressed in RPE. We conclude that miRNA signatures can be used to classify different degrees of in vitro differentiation of RPE from human pluripotent stem cells. We suggest that RPE-specific miRNAs likely contribute to the functional maturation of RPE in vitro, similar to the regulation of RPE-specific mRNA expression.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22848339 PMCID: PMC3407211 DOI: 10.1371/journal.pone.0037224
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1ES-derived RPE have distinctive global miRNA signatures.
A) Morphological features of four stages during human pluripotent stem cells differentiate into RPE cells. a, human ES cells; b, partially differentiated ES cells after 4 days withdraw bFGF; c, pigment cluster appeared after about 30 days differentiation; d, RPE monolayer. Scare bar: (a–c) 100 μm; (b) 50 μm. B, C) MiRNA profiles of different cell types were clustered using either unbiased hierarchical clustering or principal component analysis (PCA). B) Pearson correlation clustering between all cell lines. C) 3D-biplot of the first three principal components. Various somatic tissues were downloaded from GEO database.
Figure 2Select miRNAs are dynamically expressed during differentiation of H9 ES cell line.
Representative miRNA expressions that are A) down-regulated or B) up-regulated during the course of differentiating H9 ESCs. All values were normalized to ES state, then log2 transformed. C) RT-PCR analysis of different RPE differentiation stage showing miR-23a, miR125a, miR-125b, miR-302d and let-7g expression relative to H9 ESC stage. The relative expression levels for each miRNA were normalized by hsa-U6 control. PD = partially differentiated, PC = pigmented clusters, ES = embryonic stem cells.
Downregulated miRNAs in RPEs during ESC differentiation.
| miRNA | H9 ESC | H9 RPE | log2(fold change) |
| hsa-miR-106b | 2779 | 147 | −4.2 |
| hsa-miR-130a | 1032 | 61 | −4.1 |
| hsa-miR-130b | 521 | 19 | −4.8 |
| hsa-miR-1323 | 106 | 1 | −6.4 |
| hsa-miR-15a | 166 | 30 | −2.5 |
| hsa-miR-15b | 277 | 15 | −4.2 |
| hsa-miR-16-2 | 549 | 240 | −1.2 |
| hsa-miR-17 | 5685 | 694 | −3.0 |
| hsa-miR-18a | 1387 | 44 | −5.0 |
| hsa-miR-25 | 440 | 84 | −2.4 |
| hsa-miR-301a | 88 | 6 | −3.8 |
| hsa-miR-302c | 9948 | 1 | −13.3 |
| hsa-miR-302d | 6481 | 1 | −12.4 |
| hsa-miR-32 | 236 | 11 | −4.5 |
| hsa-miR-33a | 62 | 3 | −4.2 |
| hsa-miR-363 | 3845 | 21 | −7.5 |
| hsa-miR-373 | 450 | 1 | −8.8 |
| hsa-miR-374a | 2329 | 66 | −5.1 |
| hsa-miR-512-1 | 399 | 1 | −8.6 |
| hsa-miR-516b-2 | 130 | 1 | −7.0 |
| hsa-miR-548f-1 | 361 | 1 | −8.5 |
| hsa-miR-598 | 555 | 3 | −7.5 |
| hsa-miR-93 | 2340 | 377 | −2.6 |
| hsa-miR-96 | 174 | 2 | −6.6 |
Numbers are normalized miRNA counts in each library.
Upregulated miRNAs in RPE during ESC differentiation.
| miRNA | H9 ESC | H9 RPE | log2(fold change) |
| hsa-let-7a-2 | 305 | 9107 | 4.9 |
| hsa-let-7c | 20 | 1288 | 6.0 |
| hsa-let-7f-1 | 115 | 11339 | 6.6 |
| hsa-let-7f-2 | 118 | 11685 | 6.6 |
| hsa-let-7g | 11 | 11615 | 10.0 |
| hsa-let-7i | 7 | 9875 | 10.5 |
| hsa-miR-100 | 13 | 6309 | 8.9 |
| hsa-miR-125a | 37 | 19072 | 9.0 |
| hsa-miR-125b-1 | 19 | 39452 | 11.0 |
| hsa-miR-125b-2 | 18 | 38627 | 11.1 |
| hsa-miR-139 | 5 | 91 | 4.2 |
| hsa-miR-151b | 10 | 57 | 2.5 |
| hsa-miR-152 | 13 | 2087 | 7.3 |
| hsa-miR-181d | 1 | 122 | 6.9 |
| hsa-miR-214 | 2 | 602 | 8.2 |
| hsa-miR-22 | 25 | 2563 | 6.7 |
| hsa-miR-222 | 167 | 1640 | 3.3 |
| hsa-miR-23a | 52 | 3188 | 5.9 |
| hsa-miR-26a-1 | 636 | 6842 | 3.4 |
| hsa-miR-26a-2 | 639 | 6848 | 3.4 |
| hsa-miR-3120 | 2 | 602 | 8.2 |
| hsa-miR-4521 | 16 | 156 | 3.3 |
| hsa-miR-98 | 3 | 930 | 8.3 |
RPE signature genes associated with downregulated miRNAs.
| ADAM9 | MYRIP |
| ANKRD12 | NAV3 |
| CDH1 | NEDD4L |
| CDO1 | PITPNA |
| CLCN4 | PKNOX2 |
| CRIM1 | RAB38 |
| DIXDC1 | RHOBTB3 |
| DMXL1 | RPE65 |
| ENPP2 | RRAGD |
| FRZB | SDC2 |
| GAS1 | SGK3 |
| ITGAV | SMAD6 |
| ITM2B | SORBS2 |
| MAB21L1 | TIMP3 |
| MBNL2 | TRPM1 |
| MET | TYRP1 |
| MFAP3L | VEGFA |
Figure 3RPE-specific miRNA expression.
Heatmap representing all miRNAs that are significantly up- or down-regulated compared to other somatic tissues.
Figure 4Human-mouse RPE miRNA interaction network for assembly of RPE signature genes.
The network shows human-mouse RPE miRNA shared RPE signature genes, blue nodes are only targeted by one specie, purple nodes are shared by two species.